| Scott A Buck, MD | |
|
502 Marquette St, Valparaiso, IN 46383 | |
| (219) 464-8223 | |
| (219) 531-2356 |
| Full Name | Scott A Buck |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 27 Years |
| Location | 502 Marquette St, Valparaiso, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801856943 | NPI | - | NPPES |
| 200311720 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 01048897A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Health - Porter | Valparaiso, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Indiana Eye And Laser Center Pc | 5193701340 | 6 |
News Archive
Associations between population density, neighbourhood deprivation and the risk of developing schizophrenia or depression can be attributed to familial selection factors rather than the local environment itself, research suggests.
Despite a risk of stroke, left ventricular assist devices (LVADs) – heart pumps – work better than medical therapy in keeping seriously ill congestive heart failure patients alive, according to Columbia researchers.
CeNeRx BioPharma, Inc. has announced the initiation of human clinical trials of Tyrima, CeNeRx's new drug candidate with a triple mechanism of action for the treatment of depression and anxiety.
Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.
› Verified 4 days ago
| Entity Name | Northwest Indiana Eye & Laser Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336212117 PECOS PAC ID: 5193701340 Enrollment ID: O20060111000618 |
News Archive
Associations between population density, neighbourhood deprivation and the risk of developing schizophrenia or depression can be attributed to familial selection factors rather than the local environment itself, research suggests.
Despite a risk of stroke, left ventricular assist devices (LVADs) – heart pumps – work better than medical therapy in keeping seriously ill congestive heart failure patients alive, according to Columbia researchers.
CeNeRx BioPharma, Inc. has announced the initiation of human clinical trials of Tyrima, CeNeRx's new drug candidate with a triple mechanism of action for the treatment of depression and anxiety.
Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott A Buck, MD 851 Eastport Centre Dr, Valparaiso, IN 46383-2909 Ph: (219) 464-8223 | Scott A Buck, MD 502 Marquette St, Valparaiso, IN 46383 Ph: (219) 464-8223 |
News Archive
Associations between population density, neighbourhood deprivation and the risk of developing schizophrenia or depression can be attributed to familial selection factors rather than the local environment itself, research suggests.
Despite a risk of stroke, left ventricular assist devices (LVADs) – heart pumps – work better than medical therapy in keeping seriously ill congestive heart failure patients alive, according to Columbia researchers.
CeNeRx BioPharma, Inc. has announced the initiation of human clinical trials of Tyrima, CeNeRx's new drug candidate with a triple mechanism of action for the treatment of depression and anxiety.
Few medical investigations have had the impact of the Framingham Heart Study. This study, started in 1948, was designed as a cohort, observational study of cardiovascular disease, then recognized as a growing health threat but now has emerged as much more. The Framingham Heart study came to revolutionize thinking about cardiovascular disease, change the study of epidemiology, and even force the biostatistics community to develop multivariate analysis.
› Verified 4 days ago
Judy L Davis, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 807 Glendale Blvd, Valparaiso, IN 46384 Phone: 219-531-1999 Fax: 219-465-7569 | |
Eric G Friedman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 552 W Lincolnway, Valparaiso, IN 46385 Phone: 219-464-3937 Fax: 219-462-1534 | |
John L Felton, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1620 Country Club Rd, Suite D, Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 | |
Anusha Vasamsetti, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2101 Burlington Beach Rd, Valparaiso, IN 46383 Phone: 219-462-0309 | |
Myron I Lewyckyj, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2101 Burlington Beach Rd., Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 | |
Daniel P Taglia, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2101 Burlington Beach Rd., Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 |